Ulf RosÉn
BOARD MEMBER
Dermatology
TFS International AB
Sweden
Biography
Ulf Rosén joined the Board of Directors at TFS International in 2006. Ulf is General Partner of Danish VC firm SEED Capital where he is responsible for the Medtech/Digital health investments of the Group. He is Chairman, Board Member and Founder of several companies based in Scandinavia - Chairman of LobSor Holding/LobSor Pharmaceutical and Board Member of Reapplix ApS, Acarix A/S, Curasight A/S and MagCath ApS. His previous operational positions include: President & CEO of NeoPharma AB; General Manager of Fresenius-Kabi (Sweden & UK); Executive Vice President Global Nutrition Division at Fresenius-Kabi; and, President & CEO of Pharmacia & Upjohn (Norway). In addition, he has held Chairman and Board Memberships with several life science companies including Connect Uppsala and the Swedish Trade Association.
Research Interest
His research areas of interest are Dermatology, Pharma and Clinical Trials.
